[Glutamic acid antagonists as antiparkinson agents?].
W J
WJ
Schmidt
D000818:Animals; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D018691:Excitatory Amino Acid Antagonists; D018698:Glutamic Acid; D010300:Parkinson Disease / Q000188:drug therapy
D000978:Antiparkinson Agents; D018691:Excitatory Amino Acid Antagonists; D018698:Glutamic Acid
Glutaminsäure-Antagonisten als Parkinsonmittel?